Bixiye
P87-19 New Medical, Medical Drug and Behavioral Health Policy Management Updates- Effective January 6, 2020
Taariikhda uu dhaqangalayo Barnaamijka: Des 02, 2019
Dukumentiyadda & Foomamka Natiijooyinka
Soo bandhiga 2131 - 2140 ee natiijooyinka 3613
Bixiye
P86-19 Compliance with SAMSHA Part 2 Regulations and Identifying Claims Subject to Federal Confidentiality of Substance Use Disorder Regulations
Taariikhda uu dhaqangalayo Barnaamijka: Des 02, 2019
Bixiye
P88-19 Mental Health Adult and Child Crisis Services Billing
Taariikhda uu dhaqangalayo Barnaamijka: Des 02, 2019
Bixiye
2019 December Bulletins
Taariikhda uu dhaqangalayo Barnaamijka: Des 02, 2019
Bixiye
QP82R1-19 Pharmacy Benefit Update - $0 Insulin Member Cost-Share Benefit for Commercial Lines of Business
Taariikhda uu dhaqangalayo Barnaamijka: Nov 27, 2019
Bixiye
QP95-19 New Drug, Reyvow™ (lasmiditan) Will Require Prior Authorization (PA)
Taariikhda uu dhaqangalayo Barnaamijka: Nov 27, 2019
Bixiye
QP93-19 Provider Cost Data Update
Taariikhda uu dhaqangalayo Barnaamijka: Nov 27, 2019
Bixiye
QP99-19 Pharmacy Benefit Exclusion for Rapatha ®
Taariikhda uu dhaqangalayo Barnaamijka: Nov 27, 2019
Bixiye
QP96-19 Pharmacy Benefit Exclusion for PolivyTM, KanjintiTM, Evenity ®, BelrapzoTM, MvasiTM, Clinolipid 20%, Cisplatin, Heparin Sodium, and Selenious acid
Taariikhda uu dhaqangalayo Barnaamijka: Nov 27, 2019